Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase

Kidney International
T Iwamoto, Satomi Kita

Abstract

Hypertension is the most prevalent risk factor for stroke, myocardial infarction, or end-stage renal failure. The critical importance of excess salt intake in the pathogenesis of hypertension is widely recognized, but the mechanisms whereby salt intake elevates blood pressure have puzzled researchers. Recent studies using Na+/Ca2+ exchange inhibitors and genetically engineered mice provide evidence that vascular Na+/Ca2+ exchanger type 1 (NCX1) is involved in the development of salt-dependent hypertension. Endogenous cardiac glycosides, which may contribute to salt-dependent hypertension, seem to be necessary for NCX1-mediated hypertension. Intriguingly, studies using knock-in mice with modified cardiac glycoside binding affinity of Na+,K+-ATPases provide a clear demonstration that this cardiac glycoside-binding site plays an important role in blood pressure regulation. Taken all together: (1) endogenous cardiac glycosides are secreted after high salt intake; (2) these cardiac glycosides inhibit Na+,K+-ATPase in vascular smooth muscle cells; (3) this inhibition results in the elevation of local Na+ on the submembrane area; and (4) this elevation of local Na+ facilitates Ca2+ entry through NCX1, resulting in vasoconstriction. Th...Continue Reading

References

Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J M HamlynJ H Ludens
Jan 1, 1990·Journal of Hypertension·S M FriedmanM Tanaka
Oct 27, 1983·The New England Journal of Medicine·J J CurtisA G Diethelm
Sep 1, 1980·The American Journal of Medicine·T FujitaC S Delea
Oct 1, 1995·Nature Medicine·D DentonR Ardaillou
Mar 1, 1995·The Journal of General Physiology·S MatsuokaK D Philipson
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·G BianchiM Ferrandi
Oct 1, 1995·Journal of the American College of Nutrition·F J Haddy, M B Pamnani
Mar 1, 1996·Hypertension·M H Weinberger
Apr 15, 1996·Annals of the New York Academy of Sciences·D W Hilgemann
Feb 1, 1996·Journal of Hypertension·J M HamlynP Manunta
Feb 1, 1997·The Journal of General Physiology·S MatsuokaK D Philipson
Aug 2, 1997·Lancet·N IwaiM Kinoshita
Feb 14, 1998·The Journal of Biological Chemistry·R SchneiderW Schoner
Jul 31, 1998·Clinical and Experimental Hypertension : CHE·J M HamlynB P Hamilton
Oct 4, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·A Goto, K Yamada
Mar 10, 2001·Cell·R P LiftonD S Geller
May 25, 2002·European Journal of Biochemistry·Zijian Xie, Amir Askari
May 25, 2002·European Journal of Biochemistry·Wilhelm Schoner
May 8, 2003·Pflügers Archiv : European journal of physiology·Beate D QuednauKenneth D Philipson
Dec 9, 2003·The Journal of Biological Chemistry·Takahiro IwamotoTakeshi Katsuragi
Jan 16, 2004·Trends in Pharmacological Sciences·Damon PoburkoCornelis van Breemen

❮ Previous
Next ❯

Citations

Jun 28, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Christopher P LarsenPatrick D Walker
May 15, 2007·The New England Journal of Medicine·Horacio J Adrogué, Nicolaos E Madias
Jun 6, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Na GuanJie Ding
Apr 2, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Chahrazed El HamelGuy Touchard
Dec 7, 2007·The American Journal of Surgical Pathology·Kammi J HenriksenAnthony Chang
Aug 19, 2008·Southern Medical Journal·Guangyan CaiXiangmei Chen
Apr 5, 2008·Clinical and Experimental Pharmacology & Physiology·Joanna M Abrams, John W Osborn
Jun 24, 2011·American Journal of Physiology. Renal Physiology·Di ZhaoL Gabriel Navar
Apr 17, 2007·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takahiro Iwamoto, Satomi Kita
Nov 28, 2013·The Journal of Antimicrobial Chemotherapy·Gregory M LairdRobert F Siliciano
Nov 11, 2008·Journal of Ethnopharmacology·M F CandeiasJ Cruz-Morais
Feb 29, 2008·Journal of Theoretical Biology·Emina SudarEsma R Isenovic
Oct 20, 2010·European Journal of Clinical Investigation·Richárd HalmaiIstván Wittmann
Nov 21, 2014·Clinical and Experimental Nephrology·Midori Sasaki YatabeTsuyoshi Watanabe
Mar 11, 2011·Acta Physiologica Hungarica·J TodorovicDusan Cemerikic
Jun 24, 2011·Journal of Human Hypertension·M L de Gusmão CorreiaC A Mandarim-de-Lacerda
May 26, 2007·Circulation Research·Juan M Saavedra
Dec 4, 2008·Journal of Hypertension·Paolo ManuntaJohn M Hamlyn
May 1, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Tracy J PritchardRichard J Paul
Feb 3, 2012·Physiological Reviews·J T SylvesterJeremy P T Ward
Oct 2, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Simon A Hirota, Luke J Janssen
Aug 3, 2007·American Journal of Physiology. Renal Physiology·Aurélie Edwards, Thomas L Pallone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.